Navigation Links
Cancer Research May Help Biofuels

Nearly a decade ago, Tom Todaro was talking to researchers at the Fred Hutchinson Cancer Research Center about techniques the institute had devised to slow down tumor// growth by slowing the rate at which tumor cells divide.

Then they had an idea. Why not exploit the reaction in reverse and get cells to grow faster?

The result was Targeted Growth, a company that has come up with techniques for increasing crop yields with canola, corn and other crops. In their natural state, these crops stop growing after a certain point in the season. Targeted Growth manipulates a plant's genetic code so the cells continue to divide past their ordinary stopping point.

In the end, the genetic manipulation leads to increased seed size and seed count. In experiments, the technique has increased overall crop yield by as much as 20 percent. It also works in a similar fashion in different plants.

"It turns out that cell cycle regulating pathways are genetically similar," he said in an interview. "Cell division is the fundamental component in life, if you think about it."

This week Capricorn Management, the investment firm of former eBay President Jeff Skoll, led a $22.3 million investment in the company. With the influx of cash, Targeted is going to test out how its technology works in a wider variety of crops in a diverse range of ecosystems.

The company, which licenses technology from the Hutchinson Center but also has devised its own technologies, does not integrate foreign genes into a plant, which creates so-called transgenic plants. Instead, it removes genes from a species, modifies them and then reinserts them.

Founded in 1999, the company has primarily worked with agribusiness concerns like Monsanto but in the past few years has begun to more closely examine using its technology for ethanol and biodiesel production. Alternative fuels have become a major focus of interest for universities, governments, the p ublic and researchers.

There is one big problem, though: they currently cost more than gas. If oil stays below $55 a barrel, most alternative car fuel technologies stop making economic sense, according to Dan Arvizu, director of the National Renewable Energy Laboratory. Oil has bounced between $50 and $60 a barrel recently. As a result, most biofuels are currently supported by subsidies.

Genetic modification helps ameliorate the problem by allowing farmers to generate more starch, which can be converted to ethanol or biodiesel, per acre. The company has already grown a dozen or so fields each of canola, corn, soybeans and camolina, a similar plant to canola.

"Now I want four dozen for each, and I want to do them worldwide," he said. Commercially, fuels enhanced by Targeted's technology may hit pumps in four years or so.

Genetic modification, Todaro admits, isn't popular with the public, but it enjoys strong support in many parts of the scientific community. It cuts down pesticide use, can help farmers earn more profits, and the evidence that it hurts humans is shaky at best.

"One of my favorite stats is that more people are killed by falling coke machines every year than genetically modified foods," he said. "Eighty percent of the corn and soy sold worldwide has biotech inside of it. You ate a transgene at breakfast this morning if you had cereal; I guarantee it."

Source-Bio-Bio Technology
SRI
'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... , ... i2i Systems, an early innovator and developer of population health management ... KLAS report, Population Health Management 2015: How Far Can Your Vendor Take You? ... (PHM). The latest KLAS Report, leveraging over 200 user interviews, shines a light ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenntag Specialties, Inc.(BSI) ... Food & Beverage and Dietary Supplement market segments across ... and USA geographies east of the Rocky Mountains since 2012. Consistent performance ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering ... pouches, bags, and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, ... step up to semi-automatic or fully-automatic case packing with a small footprint, rugged, ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... serving the greater Venice, FL area, has initiated a fundraiser for a two ... accident just four days after Christmas. To support this beautiful child who is ...
(Date:2/8/2016)... ... , ... FileHold's document management software has been implemented by ... environment for FileHold software that is pay per user subscription-based and also does ... FileHold web services API. DocuSyst also advises clients on fully functioning back up ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... LONDON , Feb.8, 2016 Cardiovascular ... Summary GlobalData,s Medical Devices sector report, ... 2015" provides an overview of Cardiovascular Surgery Devices ... --> The report provides comprehensive ... of the products at various stages of development. ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: